MedicFAQ Logo MedicFAQ
🩺 Symptoms

Nystagmus and Vertigo: Causes, Dangers, and Treatment

A comprehensive medical guide on nystagmus: what causes involuntary eye movements, how they relate to vertigo and neurological conditions, how diagnosis is made, and what treatments are available.

Dr. Gregory Ashford, MD, PhD
13 min read
Updated August 31, 2026
On this page

What is Nystagmus?

Nystagmus is the medical term for a specific type of abnormal, involuntary eye movement characterized by three fundamental properties:

  1. Oscillatory: The eyes move rhythmically from side to side (horizontal), up and down (vertical), in a circular or rotary pattern, or in combinations of these directions
  2. Rhythmic: The movements follow a repetitive, regular pattern rather than occurring randomly
  3. Involuntary: The affected individual is typically aware of the abnormal movements but is completely unable to stop or control them through conscious effort

Nystagmus is not a disease in itself. Instead, it is a symptom, a clinical sign that something has disrupted the normal neural mechanisms controlling eye movement and gaze stability. Its causes range from entirely benign physiological phenomena to serious neurological emergencies, making accurate diagnosis and appropriate specialist referral essential.

Overview of Causes

The causes of nystagmus can be broadly categorized as:

  • Physiological nystagmus: A normal phenomenon occurring in all healthy individuals under specific circumstances, with no associated pathology or identifiable disease cause
  • Pathological nystagmus: Associated with an identifiable underlying condition, most frequently involving:
    • The inner ear (vestibular system)
    • The central nervous system (neurological causes)
    • The eye itself (ocular causes)

Associated Symptoms

Although nystagmus is itself a symptom, it frequently co-occurs with other manifestations that together constitute the clinical picture. The most common associated symptoms include:

  • Vertigo: A hallucination of movement, where you feel as though the surrounding environment or your own body is spinning or tilting, even when you’re completely still
  • Nausea and vomiting: Driven by the same vestibulo-autonomic reflex pathways that produce vertigo
  • Headache (cephalgia): Particularly when nystagmus has a central (neurological) origin
  • Sleep disturbances: Difficulty initiating or maintaining restful sleep due to persistent symptoms
  • Loss of balance and postural instability: A sense of unsteadiness or imbalance that impairs walking and daily activities
  • Visual disturbances: Including oscillopsia (the subjective perception that the visual environment is oscillating or jumping), reduced visual acuity, and difficulty focusing

Diagnostic and Therapeutic Overview

Because nystagmus can have origins at multiple levels of the visual, vestibular, and central nervous systems, diagnosis frequently requires evaluation by multiple medical specialists: an ophthalmologist (for ocular causes), an otorhinolaryngologist/ENT specialist (for vestibular causes), and a neurologist (for central causes). Each specialist conducts a targeted examination and may order specific diagnostic studies.

The therapeutic principle centers on identifying and removing or treating the underlying cause wherever possible. The prognosis and treatability vary substantially depending on the cause. Some conditions, such as benign paroxysmal positional vertigo, are highly curable. Others, particularly certain central neurological conditions, can be complex and only partially treatable.


Causes and Classification

The Mechanics of Nystagmus: Fast and Slow Phases

All forms of pathological nystagmus share a characteristic biphasic structure consisting of alternating slow and fast phases:

  • Slow phase: The eyes drift gradually away from the correct fixation point in one direction. This represents the pathological component: the vestibular or neural imbalance that drives the abnormal movement.
  • Fast phase (saccadic correction): The brain detects the deviation and sends a rapid corrective signal, snapping the eyes back to the desired fixation position. This corrective movement is called a saccade.

By convention, the direction of nystagmus is defined by the direction of the fast, corrective phase, rather than the slow drift. This is important clinically because the direction of nystagmus helps localize the underlying pathology.

The entire cycle, consisting of a slow drift followed by a fast correction, occurs multiple times per second. This process produces the characteristic oscillating eye movements visible to an examiner.

Classification Parameters

Nystagmus can be classified along multiple dimensions, each carrying diagnostic significance:

By Onset

  • Congenital: Present from birth; typically associated with ocular or visual pathway disorders
  • Infantile: Develops during early childhood (typically within the first few months of life), often in the absence of detectable ocular pathology (idiopathic infantile nystagmus)
  • Acquired: Develops in adulthood or later life; more likely to have a definable neurological, vestibular, or toxic cause

By Laterality

  • Monocular: Affects only one eye; relatively rare; suggests a localized orbital or ocular motor nerve pathology
  • Binocular: Affects both eyes (most common); may be conjugate (both eyes move together) or disconjugate (eyes move independently)

By Direction

  • Horizontal: The most common form; eyes oscillate from side to side
  • Vertical: Eyes oscillate up and down; almost always indicates a central (brainstem or cerebellar) cause
  • Torsional (rotary): Eyes rotate around the visual axis; often vestibular in origin
  • Oblique: A diagonal movement combining horizontal and vertical components
  • Circular: The eyes trace a circular or elliptical path (pendular nystagmus)
  • Mixed direction: Combinations of the above

By Symmetry

  • Symmetric (conjugate): Both eyes show identical amplitude and direction
  • Asymmetric (disconjugate): The two eyes differ in amplitude, direction, or timing; suggests a structural lesion affecting the ocular motor pathways

By Duration

  • Continuous: Nystagmus is present constantly
  • Intermittent: Nystagmus recurs regularly at different times of day but is not continuously present
  • Transient/Paroxysmal: Episodes of nystagmus are separated by prolonged symptom-free intervals; characteristic of benign paroxysmal positional vertigo (BPPV)

By Severity (Degree)

Horizontal nystagmus is traditionally classified into three grades based on the gaze position that elicits it:

  • Grade 1 (First degree): Nystagmus is only present when gaze is directed toward the side of the fast phase (lateral gaze to the affected side).
  • Grade 2 (Second degree): Nystagmus is present with gaze directed straight ahead (primary position), in addition to lateral gaze.
  • Grade 3 (Third degree): Nystagmus is present in all gaze positions, including when looking toward the slow-phase direction. This represents the most severe form.

This grading system follows Alexander’s Law: nystagmus intensity increases as gaze is directed toward the fast phase.

Physiological Nystagmus

Physiological nystagmus is a normal finding in all healthy humans under specific circumstances. It does not indicate disease or pathology; rather, it represents an adaptive mechanism by which the brain and eye muscles collaborate to maintain stable visual perception despite motion.

Optokinetic Nystagmus (OKN)

The most everyday example of physiological nystagmus happens when someone tries to visually fixate on an object while either they or the object is moving. For instance, this occurs when watching a passing landscape from a moving train or car. The sequence unfolds as follows:

  1. The person fixates on a specific object in the environment (e.g., a tree by the track).
  2. As the train moves, the object drifts across the visual field. The eyes follow it smoothly, a movement known as smooth pursuit, and this motion corresponds to the slow phase.
  3. When the object reaches the limit of comfortable gaze range, the brain initiates a rapid saccade to find and fixate on the next object. This movement corresponds to the fast phase.
  4. The cycle repeats continuously.

This pattern, known as optokinetic nystagmus (OKN), is entirely normal. In fact, it is clinically useful: the presence of OKN confirms that the visual pathway and basic eye movement control circuits are intact. OKN is routinely used by ophthalmologists to assess visual acuity in pre-verbal infants.

Endpoint Nystagmus

A second form of physiological nystagmus occurs at the extremes of lateral gaze. This happens when a person looks as far as possible to one side, fatiguing the extraocular muscles. Small-amplitude nystagmus in this position is a normal finding and should not be misinterpreted as pathological. True pathological nystagmus, by contrast, occurs with less extreme gaze deviations and persists with fixation.

Caloric and Rotational Nystagmus

Nystagmus can be physiologically induced in all individuals through vestibular stimulation:

  • Caloric stimulation: Irrigating the ear canal with warm or cool water creates a temperature gradient that produces convection currents in the endolymph of the horizontal semicircular canal, artificially activating the vestibular system and inducing predictable horizontal nystagmus. This is the basis of the caloric test used in vestibular assessment.
  • Rotational stimulation: Spinning in a chair and then stopping abruptly (as in the classic “spinning in a chair” experience) induces rotational nystagmus, which reflects normal functioning of the semicircular canals.

Congenital and Infantile Nystagmus

Congenital and infantile nystagmus are considerably rarer than acquired forms. They are present from birth or develop within the first months of life and are typically bilateral and horizontal. Two main categories exist:

Ocular/Sensory-Deprivation Nystagmus

This form occurs when the developing visual system cannot establish normal fixation reflexes. The cause is reduced or absent visual input during early infancy, which is a critical period for visual system maturation. The nystagmus is a neurological consequence of abnormal visual development rather than a primary motor abnormality.

Causes include:

  • Optic nerve atrophy: Degeneration or hypoplasia of the optic nerves significantly reduces visual input
  • Retinal malformations: Including cone dystrophy, rod-cone dystrophy (retinitis pigmentosa), achromatopsia, Leber congenital amaurosis, and other hereditary retinal disorders
  • Congenital bilateral glaucoma: Chronically elevated intraocular pressure damages the optic nerve and cornea
  • Congenital bilateral cataracts: Opacification of the crystalline lens severely degrades the visual image reaching the retina; if not surgically corrected within weeks of birth, irreversible nystagmus and amblyopia develop
  • Congenital ocular toxoplasmosis and other intrauterine infections, such as CMV, rubella, and herpes simplex (collectively known as the TORCH group), can damage the retina, optic nerve, or visual cortex before birth
  • Albinism: Associated with foveal hypoplasia and abnormal decussation of optic nerve fibers at the chiasm, producing nystagmus in virtually all affected individuals
  • Aniridia: Congenital absence of the iris, associated with foveal hypoplasia and nystagmus

Idiopathic Infantile Nystagmus (INS)

Previously called “congenital motor nystagmus”, INS presents within the first few months of life without identifiable ocular or neurological pathology. It is typically horizontal, conjugate, and pendular or jerk in character. A family history is frequently present, and genetic mutations in the FRMD7 gene (X-linked) and other loci have been identified. Visual acuity is variably reduced. Many affected individuals develop a characteristic null zone, which is a specific gaze direction where the nystagmus amplitude is minimal and vision is best. To maintain their eyes in this optimal position, they often adopt a compensatory head turn or tilt.

Vestibular Nystagmus

Vestibular nystagmus originates from pathology within the peripheral vestibular apparatus, which includes the inner ear structures responsible for sensing head position and movement in space, or from issues in the central vestibular pathways.

Anatomy and Function of the Vestibular System

To understand vestibular nystagmus, a brief review of vestibular anatomy is essential. The peripheral vestibular apparatus in the inner ear consists of:

  • Three semicircular canals (anterior, posterior, and horizontal) detect angular acceleration: rotational movements of the head in three planes of space. Each canal is filled with endolymph (a fluid) and contains a sensory receptor called the crista ampullaris. When the head rotates, endolymph movement deflects the cupula (a gelatinous membrane) overlying the crista, triggering neural signals that inform the brain of head rotation direction and speed.
  • Utricle and saccule (the otolith organs): Detect linear acceleration and the position of the head relative to gravity. They contain otoconia, tiny calcium carbonate crystals embedded in a gelatinous membrane, which shift in response to gravitational and linear forces. This movement stimulates the underlying hair cells.

The vestibular system is closely linked to the ocular motor system through the vestibulo-ocular reflex (VOR). This reflex produces compensatory eye movements in the opposite direction of head movement, ensuring the visual image remains stable on the retina during head motion. Disruption of this reflex produces nystagmus.

The two vestibular systems (one in each inner ear) maintain a tonic balance of neural signals to the brainstem. When one side is damaged or overstimulated, the tonal imbalance is interpreted by the brain as ongoing rotation, generating compensatory nystagmus directed away from the damaged side.

Benign Paroxysmal Positional Vertigo (BPPV) and Canalolithiasis

Benign paroxysmal positional vertigo (BPPV), also called canalolithiasis or cupulolithiasis, is by far the most common cause of vestibular nystagmus and the most frequent cause of vertigo in clinical practice. Its mechanism is elegantly straightforward:

  • Otoconia, which are the calcium crystals in the utricle, become dislodged from their normal position and migrate into one of the semicircular canals. This most commonly occurs in the posterior semicircular canal.
  • Within the canal, these displaced crystals behave as free-floating particles (canalolithiasis) or adhere to the cupula (cupulolithiasis).
  • When the head is moved into certain positions, these crystals create abnormal fluid currents in the semicircular canal, generating neural signals that falsely indicate rotation.
  • The brainstem receives conflicting information (the canal signals rotation while the opposing canal signals nothing) and responds with both vertigo and nystagmus.

The resulting nystagmus in posterior canal BPPV is characteristic: geotropic, torsional-vertical, occurring after a latency of a few seconds following a provocative head position change, lasting less than 60 seconds, fatiguing with repeated testing, and accompanied by intense, briefly incapacitating vertigo.

The diagnosis is confirmed by the Dix-Hallpike maneuver (for posterior canal BPPV) or the roll test (for horizontal canal BPPV).

Labyrinthitis and Vestibular Neuritis

Labyrinthitis is an inflammatory condition of the labyrinth (the membranous inner ear structure housing both the cochlea and the vestibular apparatus), while vestibular neuritis specifically affects the vestibular nerve without cochlear involvement. Both typically result from viral infection (most commonly reactivation of herpes simplex virus type 1 or other neurotropic viruses).

Clinical features include:

  • Acute, sustained vertigo lasting days to weeks (unlike the brief vertigo of BPPV).
  • Nausea and vomiting, often severe during the acute phase, are common symptoms.
  • Nystagmus directed away from the affected side (the intact side “wins” the tonal competition).
  • Hearing loss and tinnitus (if the cochlea is also involved, which indicates labyrinthitis rather than vestibular neuritis).
  • No neurological symptoms (absence of diplopia, dysarthria, dysphagia, limb ataxia distinguishes peripheral from central vestibular disorder).

Recovery occurs over weeks as the CNS undergoes vestibular compensation, a process of neural plasticity. During this process, the brainstem adapts to the persistent asymmetric input.

Ménière’s Disease

Ménière’s disease is a chronic condition of the inner ear characterized by the pathological accumulation of endolymph (endolymphatic hydrops) due to impaired reabsorption. The classic tetrad of symptoms, which are typically episodic and recurring, includes:

  1. Episodic vertigo: Severe rotational vertigo attacks lasting 20 minutes to 12 hours, accompanied by nausea and vomiting.
  2. Fluctuating sensorineural hearing loss: Initially affecting low frequencies, progressively becoming permanent over years.
  3. Tinnitus: Roaring, buzzing, or ringing in the affected ear.
  4. Aural fullness: A sense of pressure or fullness in the ear preceding attacks.

Nystagmus is invariably present during acute attacks, directed toward the affected ear during the irritative phase and away from it during the paralytic phase (after the attack). The underlying mechanism involves periodic ruptures of the membranous labyrinth due to fluid pressure buildup.

Vascular Disorders of the Inner Ear

Blood flow disruption to the inner ear, caused by thromboembolism, vasospasm, or other ischemic processes affecting the anterior inferior cerebellar artery (AICA) or its labyrinthine artery branch, may result in sudden and severe vestibular dysfunction. This can result in vertigo, hearing loss, and nystagmus. This must be distinguished from brainstem or cerebellar infarction (see below), as the latter carries a much higher risk of life-threatening complications.

Trauma

Blunt or penetrating head trauma affecting the temporal bone can damage the membranous labyrinth, semicircular canals, or vestibular nerve, producing nystagmus. Perilymphatic fistula, an abnormal communication between the perilymph space and the middle ear, may follow barotrauma or head impact.

Drug and Toxin-Induced Vestibular Nystagmus

Multiple substances can cause or precipitate nystagmus through vestibular or central mechanisms:

  • Alcohol: Acute alcohol intoxication causes position-dependent nystagmus due to differential diffusion of alcohol into the cupula; chronic alcoholism causes permanent cerebellar-vestibular dysfunction
  • Aminoglycoside antibiotics (gentamicin, tobramycin, streptomycin): Selectively vestibulotoxic (and ototoxic); can permanently destroy hair cells of the vestibular apparatus and cochlea.
  • Anticonvulsants (phenytoin, carbamazepine): A common dose-dependent side effect of these medications is horizontal gaze-evoked nystagmus.
  • Benzodiazepines and sedative-hypnotics: Suppress central vestibular function and can cause nystagmus at higher doses.
  • Quinine and related compounds: Ototoxic at high doses.

Neurological Nystagmus

Nystagmus of central (neurological) origin is generally a more serious finding than peripheral vestibular nystagmus and often indicates pathology in the brainstem, cerebellum, or their connections. It is relatively common in the elderly population with significant cardiovascular risk factors.

Key Clinical Features Distinguishing Central from Peripheral Nystagmus

Understanding the differences between central and peripheral nystagmus is critically important for emergency triage, as central causes (particularly cerebellar or brainstem stroke) can be life-threatening:

FeaturePeripheral (Vestibular)Central (Neurological)
DirectionUnidirectional (typically horizontal-torsional)May be bidirectional, purely vertical, or purely torsional
Fixation effectSuppressed by visual fixationNOT suppressed by fixation
Severity of vertigoUsually intenseOften mild or absent
Head impulse testPositive (corrective saccade present)Negative
OnsetTypically acuteVariable
Associated symptomsRare neurological signsDiplopia, dysarthria, dysphagia, ataxia, facial numbness possible

A purely vertical nystagmus (upbeat or downbeat) is virtually never of peripheral origin and should be considered a central finding until proven otherwise.

Stroke (Cerebrovascular Accident)

Cerebral stroke, whether ischemic due to arterial occlusion or hemorrhagic, may cause nystagmus as a prominent feature when it affects key structures of the posterior circulation. Critical anatomical locations include:

  • Cerebellum: The cerebellum plays a fundamental role in controlling smooth pursuit eye movements, gaze-holding, and the VOR. Cerebellar strokes, especially those affecting the posterior inferior cerebellar artery (PICA) territory (Wallenberg syndrome) or the anterior inferior cerebellar artery (AICA) territory, produce characteristic nystagmus patterns. These strokes are often accompanied by ipsilateral ataxia, dysarthria, and Horner’s syndrome.
  • Brainstem (pons and medulla): The brainstem contains the paramedian pontine reticular formation (PPRF), which serves as the horizontal gaze center. It also includes the interstitial nucleus of Cajal and riMLF, both of which function as the vertical gaze centers. Lesions in these areas produce characteristic gaze palsies and nystagmus patterns.
  • Optic tract and nucleus: Lesions of the visual pathway proper can occasionally produce nystagmus through impaired afferent signals.
  • Cranial nerve nuclei (III, IV, VI): Direct involvement of the ocular motor cranial nerve nuclei or their fascicles can produce both nystagmus and complex gaze abnormalities.

The HINTS examination (Head Impulse, Nystagmus, Test of Skew) is an evidence-based clinical tool that can reliably distinguish central from peripheral vestibular syndrome in patients presenting with acute vestibular syndrome, with sensitivity and specificity for stroke comparable to early MRI.

Brain Tumors

Primary brain tumors (glioma, meningioma, acoustic neuroma/vestibular schwannoma, ependymoma) and metastatic lesions can produce nystagmus by:

  • Direct compression of the brainstem, cerebellum, or ocular motor pathways.
  • Increased intracranial pressure (causing false localizing signs including VI nerve palsy and associated eye movement abnormalities).
  • Infiltration of specific neural structures.

Vestibular schwannoma (also called acoustic neuroma) is a benign, slow-growing tumor that develops from the Schwann cells of the vestibulocochlear nerve. It typically causes progressive unilateral sensorineural hearing loss, tinnitus, and, over time, nystagmus. These symptoms occur as the tumor enlarges and compresses the brainstem.

Multiple Sclerosis

Multiple sclerosis (MS) is a demyelinating disease of the central nervous system that can produce multiple distinct nystagmus types depending on lesion location:

  • Internuclear ophthalmoplegia (INO): One of the most characteristic neuro-ophthalmic manifestations of MS. It is caused by a demyelinating lesion in the medial longitudinal fasciculus (MLF), the neural tract that connects the abducens nucleus on one side to the medial rectus subnucleus on the other. The result is impaired adduction of the ipsilateral eye with abduction nystagmus of the contralateral eye on horizontal gaze testing.
  • Pendular nystagmus: A specific form with smooth, equal-velocity oscillations in all phases (no distinct fast and slow components); commonly seen in MS and associated with impaired vision (oscillopsia).
  • Gaze-evoked nystagmus: From cerebellar or cerebellar pathway lesions.

Epilepsy

Epilepsy, especially seizures that originate in the occipital cortex or affect ocular motor areas, can cause ictal (during seizure) or post-ictal nystagmus. Oculomotor epilepsy is characterized by tonic or clonic deviation of the eyes, sometimes accompanied by nystagmus-like jerking.

Drug-Induced Central Nystagmus

Several pharmacological agents commonly cause nystagmus through central mechanisms:

  • Phenytoin and carbamazepine: Dose-dependent horizontal gaze-evoked nystagmus is a reliable early sign of toxicity.
  • Lithium: Can cause persistent downbeat nystagmus even at therapeutic levels in susceptible individuals.
  • Alcohol: Causes positional alcohol nystagmus (PAN) acutely and permanent cerebellar-type nystagmus in chronic heavy users.
  • Ketamine, PCP, and dissociative agents: Produce prominent nystagmus (often vertical or rotary) as a clinical sign of intoxication.
  • Barbiturates and benzodiazepines: Horizontal nystagmus at high doses.

Symptoms

Nystagmus is a symptom that involves the observable involuntary oscillation of one or both eyes. However, it is rarely an isolated finding. The full clinical picture depends on the underlying cause and typically includes a constellation of associated symptoms:

Primary Symptom: Involuntary Eye Movements

The defining feature is the observable, rhythmic, oscillatory movement of one or both eyes, which the patient cannot voluntarily suppress. The movement may be:

  • Horizontal, vertical, torsional, or mixed.
  • Continuous or paroxysmal (triggered by specific head positions in BPPV).
  • Variable in amplitude and frequency.

The patient may be more or less aware of the eye movements themselves. What they typically notice, however, are the consequences: visual instability and the associated symptoms below.

Vertigo

Vertigo, which is the false perception of rotational or translational self-motion or environmental motion, ranks among the most common and distressing symptoms, especially in cases of vestibular nystagmus. It ranges from mild unsteadiness to severe, incapacitating spinning sensations accompanied by intense autonomic disturbance. The duration of vertigo provides important diagnostic clues:

  • Seconds: Typically BPPV.
  • Minutes to hours: Typically Ménière’s disease or TIA.
  • Days to weeks: Typically vestibular neuritis or labyrinthitis.

Nausea and Vomiting

Nausea and vomiting occur when the vestibulo-autonomic pathways are activated. These pathways consist of neural connections linking the vestibular nuclei to both the vagal dorsal motor nucleus and the vomiting center in the medulla. These symptoms can be severe and debilitating during acute vestibular crises, particularly in Ménière’s attacks and vestibular neuritis.

Headache and Photophobia

Headache is more commonly linked to central causes of nystagmus. In particular, posterior fossa strokes and tumors may cause both headache, resulting from raised intracranial pressure or meningeal irritation, and nystagmus simultaneously. The association of sudden severe headache (“thunderclap headache”) with nystagmus and vertigo is a red-flag presentation potentially indicating cerebellar hemorrhage.

Photophobia (light sensitivity) may accompany migraine-associated vestibular disorders.

Sleep Disturbances

Chronic nystagmus and persistent vestibular symptoms can severely disrupt sleep architecture, making it difficult to fall asleep and maintain restful sleep. The sense of instability or spinning may be exacerbated by position changes in bed.

Postural Instability and Falls

The loss of accurate vestibular information about body position impairs the normal contribution of the vestibular system to postural control. This impairment leads to unsteadiness and difficulty walking, particularly in the dark when visual compensation is not possible. It also increases the risk of falls in elderly patients. This is a particularly important safety concern and a major driver of morbidity in chronic vestibular disorders.

Visual Disturbances

  • Oscillopsia: The most characteristic visual disturbance in nystagmus. It is a visual illusion where stationary objects appear to oscillate, bounce, or jump. It is most prominent with acquired nystagmus; patients with congenital nystagmus often adapt and do not experience oscillopsia because the brain learns to suppress the abnormal visual input.
  • Blurred vision: From the inability to maintain stable fixation.
  • Reduced visual acuity: Particularly during fast nystagmus phases.

Neurological Symptoms of Raised Intracranial Pressure

When nystagmus is caused by intracranial pathology (tumor, hemorrhage, large infarct), additional neurological symptoms from raised intracranial pressure may be present:

  • Progressive headache, worse in the morning or with Valsalva.
  • Nausea and vomiting (from pressure on the medullary vomiting center).
  • Papilledema (swelling of the optic disc) on fundoscopic examination.
  • Altered consciousness in severe cases.

Diagnosis

Given the broad differential diagnosis of nystagmus, which ranges from benign positional vertigo to life-threatening intracranial pathology, a systematic and thorough evaluation is essential. The diagnostic workup is ideally coordinated across multiple specialists: ophthalmologist, otorhinolaryngologist (ENT), and neurologist.

Emergency Assessment: Ruling Out Central Pathology First

The first and most critical step is excluding neurological emergencies, particularly acute cerebellar or brainstem stroke. The clinical features that should prompt urgent neuroimaging (emergency CT or MRI) include:

  • Purely vertical nystagmus (upbeat or downbeat)
  • Nystagmus that does not suppress with visual fixation
  • Direction-changing nystagmus (changes direction with gaze direction)
  • Negative head impulse test in a patient with acute vertigo and nystagmus (highly sensitive for central pathology)
  • Associated neurological signs: Diplopia, dysarthria, dysphagia, facial numbness, limb weakness or incoordination, Horner’s syndrome
  • Sudden severe headache accompanying nystagmus
  • Significant gait ataxia (inability to stand unaided)
  • Known risk factors for stroke (hypertension, atrial fibrillation, diabetes, smoking)

Clinical History

A comprehensive history should address:

  • Onset and duration: Sudden vs. gradual; constant vs. episodic
  • Triggers: Head position changes (BPPV), specific activities, medications
  • Associated symptoms: Vertigo, hearing loss, tinnitus, ear fullness, headache, neurological symptoms
  • Evolution: Progressive, stable, or improving
  • Relevant medical history: Cardiovascular risk factors, prior ear disease, neurological conditions, toxic exposures, medications
  • Family history: Particularly for congenital forms

Ophthalmological Assessment

The ophthalmologist performs:

  • Slit-lamp examination: Assessing anterior and posterior segment structures (lens, retina, optic disc)
  • Fundoscopy: Evaluating the optic disc (papilledema, atrophy), macula, and retinal vasculature
  • Visual acuity testing: Including testing at the null zone in congenital nystagmus
  • Cover-uncover and alternate cover tests: Assessing for latent nystagmus and phoria
  • Ocular motility examination: Characterizing nystagmus direction, amplitude, and response to fixation

Otorhinolaryngological/Vestibular Assessment

The ENT specialist evaluates:

  • Hearing assessment (audiometry): Pure-tone audiometry, speech audiometry, and tympanometry to detect sensorineural hearing loss (Ménière’s disease, labyrinthitis, acoustic neuroma) or conductive hearing loss.
  • Dix-Hallpike maneuver: Gold standard for diagnosing posterior canal BPPV; the characteristic geotropic torsional-vertical nystagmus with latency and fatigability is pathognomonic.
  • Roll test (supine roll test): For diagnosing horizontal canal BPPV.
  • Frenzel goggles or video-oculography: These use lenses with +20 diopters to eliminate visual fixation. This removal of fixation allows nystagmus, previously suppressed by fixation and likely of peripheral origin, to become visible. By preventing suppression, these tools can unmask peripheral nystagmus.
  • Caloric testing: Irrigating each ear with warm (44°C) and cold (30°C) water and measuring the nystagmus response; compares the responsiveness of the two labyrinths (canal paresis indicates a hypoactive labyrinth; directional preponderance indicates asymmetric tonic vestibular activity).
  • Video head impulse test (vHIT): Measures the VOR gain by rapidly rotating the head and measuring compensatory eye movements with high-speed cameras; abnormal gain and corrective saccades indicate peripheral vestibular hypofunction.

Neurological Assessment

  • Full neurological examination: Including mental status, cranial nerve testing, coordination (finger-nose, heel-shin), gait assessment, Romberg test, and assessment for long-tract signs.
  • HINTS examination: A highly sensitive clinical algorithm for distinguishing peripheral from central acute vestibular syndrome, combining the Head Impulse test, Nystagmus pattern, and Test of Skew.

Electro-oculography (EOG) and Videonystagmography (VNG)

Electro-oculography records eye movements using electrodes placed around the orbit that detect changes in the corneoretinal potential. Videonystagmography (VNG) uses infrared video cameras in goggles to record eye movements with high temporal resolution. Both techniques:

  • Quantify nystagmus (amplitude, frequency, slow-phase velocity).
  • Record eye movements during caloric, positional, and oculomotor testing.
  • Provide objective documentation for comparison over time or after treatment.

Neuroimaging

  • MRI (Magnetic Resonance Imaging): The gold standard for posterior fossa imaging; MRI with gadolinium contrast can identify:

    • Brainstem and cerebellar infarcts or hemorrhages.
    • Demyelinating plaques (multiple sclerosis).
    • Brain tumors and metastases.
    • Acoustic neuromas, also known as vestibular schwannomas, are best seen on T2-weighted or CISS sequences.
    • Note: Acute cerebellar infarction may be MISSED on MRI within the first 24–48 hours; if clinical suspicion is high, repeat imaging is warranted.
  • CT scan: Superior to MRI for detecting acute hemorrhage and bony temporal bone pathology; typically the first-line emergency neuroimaging study due to speed and availability

Additional Investigations

  • Blood tests: Full blood count, coagulation studies, fasting glucose, HbA1c, lipid panel, thyroid function, B12 and folate, inflammatory markers, drug levels (anticonvulsants, lithium)
  • Electroencephalogram (EEG): If epileptic nystagmus is suspected
  • Lumbar puncture: If meningitis, subarachnoid hemorrhage (CT-negative), or CNS infection is suspected

Treatment

The treatment of nystagmus is etiological, meaning it focuses on identifying and, whenever possible, eliminating or managing the underlying cause. There is no single universal pharmacological treatment for nystagmus; management must be tailored to the specific condition responsible.

Vestibular Nystagmus: Canalith Repositioning Procedures

For nystagmus caused by BPPV, which is the most common form of vestibular nystagmus, treatment is highly effective and often immediately curative.

Epley maneuver (for posterior canal BPPV): The otorhinolaryngologist or physiotherapist guides the patient through a sequence of precisely defined head and body position changes that harness gravity to move the displaced otoconia out of the semicircular canal and back into the utricle. This procedure achieves resolution of nystagmus and vertigo in approximately 80–90% of patients with a single session, with high repeatability if symptoms recur.

Semont maneuver: An alternative repositioning technique for posterior canal BPPV, with comparable efficacy to the Epley maneuver.

Barbecue roll maneuver: Used specifically for horizontal canal BPPV; involves sequential 360° rolling of the patient in the horizontal plane.

Log roll maneuver (Gufoni maneuver): A simplified approach for horizontal canal BPPV in patients who cannot perform the full barbecue roll.

After successful treatment, patients are advised to:

  • Avoid sudden rapid head movements for 24–48 hours
  • Sleep semi-reclined for the first night
  • Return promptly if symptoms recur (BPPV recurs in approximately 30% of patients within one year)

Infectious and Inflammatory Causes

When nystagmus is caused by labyrinthitis, vestibular neuritis, or other inner ear infections:

  • Bacterial labyrinthitis: Requires urgent antibiotic therapy. Intravenous treatment is typically needed for severe cases, while oral agents may be appropriate for milder presentations. Antibiotic selection is guided by the likely source (otogenic extension from otitis media vs. meningogenic spread).

  • Viral vestibular neuritis: There is no proven antiviral therapy effective against the most common causative agents. Management includes:

    • Short-course corticosteroids (methylprednisolone taper over 21 days): Shown to improve the rate of complete vestibular recovery in some trials, though evidence remains mixed.
    • Vestibular suppressants for symptomatic relief during the acute phase:
      • Antihistamines with vestibular suppressant properties (meclizine, dimenhydrinate, promethazine).
      • Benzodiazepines (diazepam, lorazepam): Use only during acute severe symptoms, as prolonged use interferes with vestibular compensation.
      • Anticholinergics (scopolamine).
    • Antiemetics (ondansetron, metoclopramide, prochlorperazine): For nausea and vomiting.
    • Vestibular rehabilitation therapy (VRT): A specialized physiotherapy program consisting of gaze stability and balance exercises. It accelerates central vestibular compensation, making it the most evidence-based long-term intervention for residual vestibular dysfunction.

Ménière’s Disease

Management of Ménière’s disease aims to reduce the frequency and severity of attacks and prevent progressive hearing loss:

  • Dietary modification: Low-sodium diet (<1,500 mg/day), avoidance of caffeine, alcohol, and tobacco
  • Diuretics: Hydrochlorothiazide-triamterene combinations reduce endolymph production and decrease attack frequency in many patients
  • Betahistine: A histamine analogue widely used in Europe for Ménière’s disease; thought to improve microvascular circulation in the inner ear; evidence for efficacy is mixed but the drug is generally well tolerated
  • Intratympanic corticosteroids: Injections of dexamethasone or methylprednisolone through the tympanic membrane directly into the middle ear; can reduce attack frequency with minimal systemic effects
  • Intratympanic gentamicin: A vestibulotoxic aminoglycoside deliberately applied to ablate vestibular function in the affected ear; highly effective in controlling vertigo but carries risk of additional hearing loss; reserved for refractory cases
  • Endolymphatic sac surgery: Surgical decompression of the endolymphatic sac; evidence of efficacy is disputed
  • Vestibular neurectomy: Surgical section of the vestibular nerve; highly effective for vertigo control; preserves hearing; reserved for severe refractory cases

Neurological Causes

When nystagmus has a neurological etiology, complete resolution depends on successfully treating the underlying condition. This underlying condition can vary substantially, however.

  • Acute ischemic stroke affecting the cerebellum or brainstem: Treated with intravenous thrombolysis (tPA) if within the therapeutic window and mechanical thrombectomy for large vessel occlusions in eligible patients; intensive neurological monitoring; rehabilitation.
  • Intracerebral hemorrhage: Neurosurgical consultation; blood pressure management; reversal of anticoagulation if applicable; surgical evacuation in selected cases.
  • Brain tumor: Treatment depends on the tumor type, size, and location. Options include surgical resection, stereotactic radiosurgery (such as Gamma Knife), whole-brain radiotherapy, chemotherapy, or a combination of these approaches. Palliative care is recommended when curative options are not available.
  • Multiple sclerosis: Acute relapses treated with high-dose intravenous methylprednisolone; long-term disease-modifying therapies (interferons, glatiramer acetate, natalizumab, fingolimod, ocrelizumab, and others) to reduce relapse frequency and disease progression; symptomatic treatment of nystagmus with 4-aminopyridine (fampridine) or gabapentin has shown benefit in some patients with MS-related nystagmus.
  • Drug-induced nystagmus: Dose reduction or discontinuation of the offending agent typically resolves drug-related nystagmus; confirmation of drug levels and toxicity assessment are important.

Pharmacological Treatment of Nystagmus Symptoms

When the nystagmus itself causes significant functional impairment (particularly oscillopsia and reduced visual acuity), pharmacological treatment of the eye movements may be warranted:

  • Gabapentin: Has demonstrated efficacy in reducing nystagmus amplitude and improving visual acuity in acquired pendular nystagmus (common in MS) and downbeat nystagmus
  • Memantine: An NMDA receptor antagonist that has shown benefit in acquired pendular nystagmus in clinical trials
  • 4-Aminopyridine (dalfampridine/fampridine): A potassium channel blocker that has demonstrated clinically significant reduction of downbeat nystagmus and improvement in visual function in multiple trials; now considered a treatment of choice for downbeat nystagmus
  • Baclofen: A GABA-B agonist used for periodic alternating nystagmus and some forms of upbeat nystagmus
  • Clonazepam: May be helpful for some forms of central nystagmus, particularly those with a vestibular component
  • Scopolamine patches: For vestibular nystagmus with prominent motion sickness

Optical and Surgical Approaches

For congenital nystagmus where a null zone has been identified:

  • Prism glasses: Optical prisms incorporated into spectacle lenses can shift the visual image so that patients can use their null zone in the primary (straight-ahead) gaze position without adopting a compensatory head turn
  • Contact lenses: Some patients report reduced nystagmus amplitude with contact lenses compared to spectacles
  • Extraocular muscle surgery (Anderson-Kestenbaum procedure): Surgical repositioning of the extraocular muscles to shift the null zone to the primary position, allowing binocular straight-ahead vision without head turn; also used to reduce nystagmus amplitude by improving null zone properties
  • Botulinum toxin injection: Injection into the extraocular muscles can temporarily reduce nystagmus amplitude; effect lasts approximately 3 months; useful for patients not suitable for surgery

Vestibular Rehabilitation Therapy (VRT)

Vestibular rehabilitation therapy is a specialized form of physiotherapy based on the principles of central vestibular compensation and neuroplasticity. It is most effective for patients with stable or unilateral peripheral vestibular hypofunction. A comprehensive VRT program includes:

  • Gaze stabilization exercises: Training the eyes to maintain fixation on a target during head movements, stimulating central adaptation of the VOR
  • Habituation exercises: Repeated exposure to provocative head movements to desensitize the vestibular system
  • Balance training: Progressively challenging postural tasks on stable and unstable surfaces, with and without visual input
  • Gait training: Improving confidence and safety during walking on various surfaces and in demanding environments

VRT consistently reduces dizziness, improves gaze stability, enhances postural control, and decreases fall risk in patients with chronic vestibular dysfunction. It is strongly recommended as a first-line intervention for vestibular hypofunction.


Bibliography and Sources

  • Bowling B, Azzolini C, Donati S (eds). Kanski – Oftalmologia clinica. Milano: EDRA.

  • American Optometric Association. Nystagmus. Available at: https://www.aoa.org/healthy-eyes/eye-and-vision-conditions/nystagmus

  • Bhattacharyya N, Gubbels SP, Schwartz SR, et al. Clinical Practice Guideline: Benign Paroxysmal Positional Vertigo (Update). Otolaryngol Head Neck Surg. 2017;156(3_suppl):S1–S47. doi:10.1177/0194599816689667

  • Leigh RJ, Zee DS. The Neurology of Eye Movements. 5th ed. Oxford: Oxford University Press; 2015.

  • Kattah JC, Talkad AV, Wang DZ, Hsieh YH, Newman-Toker DE. HINTS to diagnose stroke in the acute vestibular syndrome: Three-step bedside oculomotor examination more sensitive than early MRI diffusion-weighted imaging. Stroke. 2009;40(11):3504–3510. doi:10.1161/STROKEAHA.109.551234

  • Strupp M, Brandt T. Peripheral vestibular disorders. Curr Opin Neurol. 2013;26(1):81–89. doi:10.1097/WCO.0b013e32835c9ca4

  • Strupp M, Teufel J, Habs M, et al. Effects of 4-aminopyridine in patients with downbeat or upbeat nystagmus in a prospective trial: Saccadic latency improvement and reduced nystagmus intensity. J Neurol. 2011;258(9):1736–1741. doi:10.1007/s00415-011-6028-3

  • Thurtell MJ, Leigh RJ. Treatment of nystagmus. Curr Treat Options Neurol. 2012;14(1):60–72. doi:10.1007/s11940-011-0154-5

  • Hain TC. Nystagmus overview. American Hearing Research Foundation. Available at: https://american-hearing.org

  • Newman-Toker DE, Kerber KA, Hsieh YH, et al. HINTS outperforms ABCD2 to screen for stroke in acute continuous vertigo and dizziness. Acad Emerg Med. 2013;20(10):986–996. doi:10.1111/acem.12223

  • Brandt T, Huppert D, Strupp M, Dieterich M. Long-term course and relapses of vestibular and balance disorders. Restor Neurol Neurosci. 2010;28(1):69–82.

Read More Like This

🩺 Symptoms

Excessive Night Sweats: Causes, Dangers, and Remedies

What causes excessive sweating during sleep, when should night sweats worry you, and how are they diagnosed and treated? A complete medical guide to nocturnal hyperhidrosis.

October 12, 2026 11 min read
Excessive Night Sweats: Causes, Dangers, and Remedies
🩺 Symptoms

Swollen Ankles and Feet: Causes, Remedies, and When to Worry

Discover the most common causes of swollen ankles and feet, from venous insufficiency to heart and kidney disease. Learn effective remedies and when swelling requires urgent medical attention.

October 12, 2026 5 min read
Swollen Ankles and Feet: Causes, Remedies, and When to Worry
❤️ Health

Retinal Detachment: Symptoms, Causes, and Treatment Options

A complete guide to retinal detachment: what it is, why it happens, warning signs to watch for, how doctors diagnose it, and the surgical and medical treatments available today.

October 11, 2026 16 min read
Retinal Detachment: Symptoms, Causes, and Treatment Options
🩺 Symptoms

Blood in Stool: Main Causes and Treatment Options

Discover the most common causes of blood in the stool, from hemorrhoids to more serious conditions, when to see a doctor, how it is diagnosed, and the available treatment options.

October 11, 2026 9 min read
Blood in Stool: Main Causes and Treatment Options
🩺 Symptoms

Hypothermia and Low Body Temperature: Symptoms, Dangers, and Treatment

A comprehensive medical guide on hypothermia: causes, risk factors, symptoms by severity grade, complications, emergency treatment, and prevention strategies. Written for the general public with authoritative medical sources.

October 11, 2026 15 min read
Hypothermia and Low Body Temperature: Symptoms, Dangers, and Treatment
🩺 Symptoms

Skin and Scalp Peeling (Desquamation): Causes, Types, and Effective Remedies

A comprehensive dermatological guide to skin and scalp peeling: what desquamation is, the conditions that cause it, how different types are classified, and the most effective medical and topical treatments available.

October 9, 2026 12 min read
Skin and Scalp Peeling (Desquamation): Causes, Types, and Effective Remedies
🩺 Symptoms

Galactorrhea: Causes, Symptoms, Diagnosis, and Treatment

Galactorrhea is the production of breast milk outside of breastfeeding and can affect women, men, and newborns. Learn the causes (from prolactinoma to medications), the associated symptoms, when to worry, how it is diagnosed, and how it is treated.

October 8, 2026 11 min read
Galactorrhea: Causes, Symptoms, Diagnosis, and Treatment
❤️ Health

Keratitis: Causes, Symptoms, Dangers, and Treatment

Eearn everything about keratitis, the inflammation of the cornea: causes (bacteria, viruses, fungi, trauma), warning symptoms, possible complications like vision loss, diagnosis, and treatment options.

October 7, 2026 12 min read
Keratitis: Causes, Symptoms, Dangers, and Treatment
🩺 Symptoms

Back Pain: Causes, Exercises, and Prevention

A complete guide to back pain: anatomy, common causes, warning symptoms, when to see a doctor, diagnostic tests, treatment options, minimally invasive procedures, and effective prevention strategies.

October 7, 2026 13 min read
Back Pain: Causes, Exercises, and Prevention
🩺 Symptoms

Black Stool (Melena): Causes, Symptoms, and When It's Dangerous

Comprehensive medical guide on black stool and melena: learn the causes, symptoms, diagnosis, complications, and treatment of upper gastrointestinal bleeding. Written by a medical professional.

October 7, 2026 15 min read
Black Stool (Melena): Causes, Symptoms, and When It's Dangerous